Paul W. Boltz, Jr.
Paul represents U.S.-listed and pre-IPO companies based in Asia on a wide range of corporate activity and cross-border transactional work, often with a U.S. public securities aspect. He also represents issuers, underwriters and private equity sponsors in connection with initial public offerings and other capital markets transactions in the United States and Hong Kong markets, as well as multiple M&A transactions.
Paul has practiced in Hong Kong since 2000, and his clients include many of China’s leading life science and high tech companies.
- Represented the Special Committee of Independent Directors of NASDAQ-listed ChinaEdu Corp. in connection with its privatization by members of the company’s management and McGraw-Hill Education.
- Represented DYNAM JAPAN HOLDINGS Co., Ltd. (HKSE Main Board, stock code 06889) as its international counsel in its listing on the Main Board of the Hong Kong Stock Exchange and concurrent Reg S/Rule 144A global offering. The IPO is notable in that DYNAM is the first Japanese company to ever have a primary listing in the Hong Kong market.
- Represented numerous private equity sponsors in a wide range of securities matters, including representing Sequoia Capital and DCM in their U.S. registered secondary offering of shares of Vipshop Holdings (NYSE: VIPS), Sequoia’s cornerstone investment in Qihoo 360 Technology concurrent with its IPO (NYSE: QIHU), and TPG in the NYSE IPO of portfolio company ShangPharma Corp.
- Represented long-time client NetEase.com, Inc. (NASDAQ Global Select: NTES), one of China’s leading online game companies and internet portal operators, in a variety of corporate matters including its establishment of an onshore/offshore joint venture with Blizzard Entertainment for the operation of World of Warcraft in China and NetEase’s US$125 million convertible notes offering.
- Represented the buyer consortium in the all-cash take private of NASDAQ-listed Ninetowns Internet Technology Group.
- Represented the buyer consortium consisting of TPG Growth and the Chairman of NYSE-listed ShangPharma in its take private transaction.
- Represented MicroPort Scientific Corporation (HKSE Main Board, stock code 853), China’s leading minimally invasive medical device manufacturer, in its initial listing in Hong Kong and concurrent global offering.
- Represented China Zenix Auto International (NYSE: ZX), China’s leading commercial vehicle wheel manufacturer, in its initial listing on the New York Stock Exchange.
- Represented China GrenTech Corporation Ltd. (NASDAQ Global Select: GRRF), a mobile network communication equipment manufacturer in China, in a variety of corporate matters including an SEC-registered secondary sale of equity securities and its subsequent privatization from the U.S. markets.
- Represent Linktone Ltd., a leading wireless services and media company based in Singapore, in a variety of corporate matters, including its initial public offering on NASDAQ, the acquisition of a majority stake in Linktone by Indonesian media conglomerate PT PT. Media Nusantara Citra Tbk. and its dual listing on the Australia Stock Exchange and subsequent voluntary delisting from NASDAQ.
- Chambers Asia: Asia's Leading Lawyers for Business (2012-2014)
- Chambers Global: The World’s Leading Lawyers for Business (2011-2014)
- Quoted, “Internet Stocks Lead Chinese Charge into US,” The Financial Times (February 26, 2014)
- Quoted, “First of NYSE-Delisted China Stocks Launches HK IPO,” The Wall Street Journal (February 14, 2014)
- Quoted, “Chinese firms returning to US market for IPOs,” Reuters (February 10, 2014)
Quoted, “Regulatory Reach – Hong Kong’s Securities and Futures Commission gets tough after a new series of fraud allegations against listed Chinese companies,” FinanceAsia (October 2014)
- Quoted, “In China, Concern About a Chill on Foreign Investments,” The New York Times (June 2, 2013)
- Co-author, "M&A Litigation Goes Global," Insights (May 2013)
- "SEC’s Charges Against Chinese Affiliates Of U.S.-Based Accounting Firms Have Broad Implications," Bloomberg BNA Securities Regulation & Law Report (April 2013)
- “Advisers’ Role in Chinese RTO Companies – Implications for Private Equity Sponsors,” Law360 (August 2012)
- Presenter, “China, the Internet & Your Business: Navigating Deals in the World’s Largest and Most Complicated Internet, Market,” Licensing Executives Society - Silicon Valley Chapter seminar, Palo Alto, CA (June 2013)
- Lead Moderator and Presenter, “Cross-Border M&A Deals: Best Practices and Worst Pitfalls. What Both the Buy- and Sell-Sides in China Need to Know,” Ropes & Gray seminar, Beijing (February 2013)
- "Risks When Delisting from the U.S. Markets," joint Ropes & Gray and Marsh seminar, Beijing, Shanghai, Guangzhou (2012)
- Presenter, “What Every China-Based U.S.-Listed Company Needs to Know About U.S. SEC Enforcement Actions,” Ropes & Gray webinar (June 2012)
- “Current Trends in Offshore Listings for Health Care Companies in China,” Podcast distributed in China to industry professionals, organized by consulting firm General Biologic (December 2010)
- “Going Private: Maximising Value in a Downmarket,” IFLR Asia M&A Summit, Hong Kong (March 2009)